Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
McKesson Corporation(MCK)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for MCK
09/16/2026: MCK (2-star) has a low Upturn Star Rating. Not recommended to BUY.
McKesson Corporation is a major provider of pharmaceutical distribution and healthcare technology services, functioning as a critical link in the medical supply chain. The company benefits from a deep-rooted, large-scale distribution infrastructure and a successful shift into high-margin specialty pharmacy and clinical technology segments. Investors are often drawn to its stable cash flows, consistent dividend profile, and resilient business model. However, the company faces risks from thin operating margins, intense competition, and persistent regulatory and legal headwinds. It is best suited for long-term investors seeking defensive stability, with a focus on monitoring its ability to integrate new technology platforms and manage specialized care market expansion.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While the company has stable long-term growth prospects, its business model is generally slower-moving than pure-play growth industries. |
| Momentum investor | Strong fit while signal remains positive | The stock has demonstrated strong relative strength performance in favorable market conditions. |
| Value investor | Strong fit | McKesson often trades at reasonable valuation multiples relative to its steady cash flow generation. |
| Dividend investor | Strong fit | The company has a consistent history of dividend payments and a sustainable payout profile. |
| Low-risk investor | Strong fit | As a critical utility-like player in healthcare, it offers lower volatility compared to higher-growth speculative stocks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock can be impacted by broader market sentiment despite its defensive nature. |
| Valuation risk | Medium | Overpayment for acquisitions or market re-ratings can impact returns. |
| Competition risk (Pharmaceutical distribution) | Medium / high | Intense pricing pressure from competitors like Cencora and Cardinal Health affects margins. |
| Business quality | Strong | The company's role as a vital link in the medical supply chain provides a durable competitive advantage. |
| Dividend income | Low | The dividend is well-covered by earnings and is considered very reliable. |
| Execution risk | Medium | Effective integration of acquired technology assets is essential for long-term growth. |
Price Behavior
Flat / Range-Bound
The stock price has been trading within a narrow range with minimal directional movement.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 27.65% | Avg. Invested days 51 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 09/16/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 104.88B USD | Price to earnings Ratio 24.45 | 1Y Target Price 980.73 |
Price to earnings Ratio 24.45 | 1Y Target Price 980.73 | ||
Volume (30-day avg) 948.6K shares | Beta 0.31 | 52 Weeks Range 684.98 - 996.84 | Updated Date 09/16/2026 |
52 Weeks Range 684.98 - 996.84 | Updated Date 09/16/2026 | ||
Dividends yield (FY) 0.36% | Basic EPS (TTM) 36.79 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| U.S. Pharmaceutical Distribution | Markup and service fees from distributing drugs to pharmacies and hospitals. | This is the company's core volume-driven business providing stable, predictable revenue. |
| Prescription Technology Solutions | Software services that facilitate prescription insurance verification and patient support. | This segment is a higher-margin, technology-driven area focused on growth. |
| Medical-Surgical Solutions | Sale and distribution of medical products and equipment to provider offices. | This segment benefits from the trend of care shifting toward outpatient and physician-office settings. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 24.45 | Forward PE 20.41 | Enterprise Value 112.74B | Price to Sales(TTM) 0.26 |
Enterprise Value 112.74B | Price to Sales(TTM) 0.26 | ||
Enterprise Value to Revenue 0.27 | Enterprise Value to EBITDA 15.03 | Shares Outstanding 116.59M | Shares Floating 116.39M |
Shares Outstanding 116.59M | Shares Floating 116.39M | ||
Percent Insiders 0.06 | Percent Institutions 93.49 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
News (Last Updated: 09/16/2026)
About McKesson Corporation
Exchange NYSE | Headquarters Irving, TX, United States | ||
IPO Launch date 1994-11-15 | CEO & Chairman Mr. Brian S. Tyler Ph.D. | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 41600 | Website https://www.mckesson.com |
Full time employees 41600 | Website https://www.mckesson.com | ||
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.